L-octanoylcarnitine

L-octanoylcarnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 311 references associated with L-octanoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for L-octanoylcarnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with L-octanoylcarnitine

MeSH term MeSH ID Detail
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Metabolic Diseases D008659 12 associated lipids
Starvation D013217 47 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Insulin Resistance D007333 99 associated lipids
Thinness D013851 11 associated lipids
Heart Failure, Systolic D054143 3 associated lipids
Total 7

PubChem Associated disorders and diseases

All references with L-octanoylcarnitine

Download all related citations
Per page 10 20 50 100 | Total 70
Authors Title Published Journal PubMed Link
DeMaison L et al. Effects of (+)-octanoylcarnitine in intact myocardium. 1988 Jan-Feb Basic Res. Cardiol. pmid:3377743
Roe CR et al. Post-mortem recognition of inherited metabolic disorders from specific acylcarnitines in tissue in cases of sudden infant death. 1987 Lancet pmid:2881073
pmid:28190699
Brass EP Metabolism of octanoyl- and palmitoylcarnitine by intact rat hepatocytes. 1989 Biochim. Biophys. Acta pmid:2730893
Millington DS and Roe CR Medium-chain acyl-CoA dehydrogenase deficiency. 1989 N. Engl. J. Med. pmid:2710197
pmid:27055779
pmid:26913383
Ojuka E et al. Measurement of β-oxidation capacity of biological samples by respirometry: a review of principles and substrates. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:26908505
Horscroft JA et al. Altered Oxygen Utilisation in Rat Left Ventricle and Soleus after 14 Days, but Not 2 Days, of Environmental Hypoxia. 2015 PLoS ONE pmid:26390043
pmid:26113437
Kim M et al. Association between arterial stiffness and serum L-octanoylcarnitine and lactosylceramide in overweight middle-aged subjects: 3-year follow-up study. 2015 PLoS ONE pmid:25781947
pmid:25454677
Donato AJ et al. The impact of ageing on adipose structure, function and vasculature in the B6D2F1 mouse: evidence of significant multisystem dysfunction. 2014 J. Physiol. (Lond.) pmid:25038241
pmid:24892382
pmid:24845952
Morand R et al. Quantification of plasma carnitine and acylcarnitines by high-performance liquid chromatography-tandem mass spectrometry using online solid-phase extraction. 2013 Anal Bioanal Chem pmid:23995505
Naccarato A et al. Identification and assay of underivatized urinary acylcarnitines by paper spray tandem mass spectrometry. 2013 Anal Bioanal Chem pmid:23907684
Alexandre-Gouabau MC et al. Maternal and cord blood LC-HRMS metabolomics reveal alterations in energy and polyamine metabolism, and oxidative stress in very-low birth weight infants. 2013 J. Proteome Res. pmid:23527880
Meadows JA and Wargo MJ Characterization of Pseudomonas aeruginosa growth on O-acylcarnitines and identification of a short-chain acylcarnitine hydrolase. 2013 Appl. Environ. Microbiol. pmid:23524670
Stride N et al. Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction. 2013 Eur. J. Heart Fail. pmid:23115323

Table of Content